Third Affiliated Hospital, Sun Yat-sen University

This study is testing a two-step blood filtering treatment for people who have a sudden, severe worsening of chronic liver failure combined with a dangerous body-wide infection (sepsis). Researchers want to see if this procedure, which removes harmful substances from the blood, c…

This study is observing how well the approved MS medication ofatumumab works and how safe it is for Chinese patients in real-world settings. It will follow 80 adults with relapsing MS to see if the drug reduces a blood marker linked to nerve damage. The goal is to gather more evi…